Sichuan Purity Pharmaceutical Technology Co., Ltd.

This study tests a new nasal spray called PRT-042 (a form of ketamine) to see if it can quickly reduce depression and suicidal thoughts in adults with major depressive disorder. About 98 participants will receive either the spray or a placebo. The main goal is to measure changes …

This study tests a new nasal spray called PRT-064040 for treating moderate to severe migraines quickly. About 456 people aged 18-75 with a history of migraines will receive either the spray or a placebo. The main goal is to see if the spray can stop pain and the most bothersome s…